First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients
Clinical trial NCT01191372 · TERMINATED
Trial details
- NCT number
- NCT01191372
- Sponsor
- Baxalta now part of Shire
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-15
- Primary completion
- 2011-12-28
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.